Contact Us
About
Our Company
Management Team
Board of Directors
Scientific Advisors
Product Candidates
Overview
CLBS12
CLBS14
CLBS16
CLBS03
Our Technologies
Overview
CD34 Cell Technology
T Regulatory Cell Technology
Publications
Investors
Overview
News
Events
Media Coverage
Corporate Presentation
Fact Sheet
Analyst Coverage
SEC Filings
Stock Information
FAQs
Corporate Governance
Disclosures
Active Clinical Trials
ESCaPE-CMD (CLBS16)
CLBS12
The Sanford Project: T-Rex Study of CLBS03
Caladrius unveils positive results of CLBS16 in CMD treatment
Caladrius unveils positive results of CLBS16 in CMD treatment
November 21, 2019
For link to full article, please
click here
.
